Carcinogenesis Advance Access originally published online on July 28, 2005
Carcinogenesis 2005 26(12):2123-2130; doi:10.1093/carcin/bgi198
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis vol.26 no.12 © Oxford University Press 2005; all rights reserved.
Relationship between UV-induced mutant p53 patches and skin tumours, analysed by mutation spectra and by induction kinetics in various DNA-repair-deficient mice
Department of Dermatology, Leiden University Medical Centre, Sylvius Laboratory, PO Box 9503, 2300 RA, Leiden, The Netherlands, 1 Laboratory of Toxicology, Pathology and Genetics and 2 Laboratory of Vaccine-Preventable Diseases, National Institute of Public of Health Effects Research, PO Box 1, 3720 BA Bilthoven, The Netherlands
* To whom correspondence should be addressed. Tel: +31 71 5271902; Fax: +31 71 5271910; Email: F.R.de_Gruijl{at}lumc.nl
Clusters of p53 immunopositive epidermal keratinocytes (so-called p53 patches, clones or foci) are found in sun or ultraviolet (UV) light-exposed skin. We investigated to what extent these p53 patches are genuine precursors of skin carcinomas in chronically irradiated hairless (SKH1) mice. The mutation spectra of exons 5–8 of the p53 gene of laser-micro-dissected mutant p53 patches and carcinomas were therefore compared. The mutations we found were mainly UV-signature mutations (C
T and CCTT at dipyrimidine sites) located at known hotspots. No significant differences were found between both spectra, indicating that all p53 patches harbour mutations with which they could progress to carcinomas. To examine whether these p53 patches can be used as tumour risk indicators, we made an extensive comparison of the induction kinetics of these patches and carcinomas in genetically modified mice with various defects in nucleotide excision repair (NER), i.e. xeroderma pigmentosum A (Xpa), Xpc and Cockayne syndrome B (Csb) and wild-type mice. In this aforementioned order, the mouse strains developed both p53 patches and carcinomas in the course of daily exposure to 40 J/m2 UV. Hence, the order in which the NER-deficient mice developed patches was predictive of the order in which they developed tumours. The induction kinetics of the patches in Xpc-deficient mice differed notably from the others: there was a stationary phase (days 13–41) where the numbers were limited to 5–10 patches per mouse before an explosive increase which ran parallel to the other groups. The chance that a p53 patch progresses to carcinoma is relatively small (estimated at 1 out of 8300–40 000/individual when the first tumour appears), but our results are strongly indicative of a causal relationship between p53 patches and carcinomas.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Maeda, S. W. Schneider, M. Kojima, S. Beissert, T. Schwarz, and A. Schwarz Enhanced photocarcinogenesis in interleukin-12-deficient mice. Cancer Res., March 15, 2006; 66(6): 2962 - 2969. [Abstract] [Full Text] [PDF]
|
|